share_log

Head to Head Survey: Advanced Biomedical Technologies (OTCMKTS:ABMT) Versus Vicarious Surgical (NYSE:RBOT)

Head to Head Survey: Advanced Biomedical Technologies (OTCMKTS:ABMT) Versus Vicarious Surgical (NYSE:RBOT)

頭對頭調查:先進生物醫學技術(OTCMKTS:ABMT)與替代手術(紐約證交所代碼:RBOT)
Defense World ·  2022/12/17 14:31

Vicarious Surgical (NYSE:RBOT – Get Rating) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.

Surgical(NYSE:RBOT-GET Rating)和Advanced Biomedical Technologies(OTCMKTS:ABMT-GET Rating)都是小盤醫療公司,但哪一家是優勢業務?我們將根據兩家公司的風險、盈利能力、股息、機構所有權、估值、收益和分析師的建議來比較它們的實力。

Profitability

盈利能力

This table compares Vicarious Surgical and Advanced Biomedical Technologies' net margins, return on equity and return on assets.

此表比較了替代外科技術公司和先進生物醫療技術公司的淨利潤率、股本回報率和資產回報率。

Get
到達
Vicarious Surgical
代替性外科
alerts:
警報:
Net Margins Return on Equity Return on Assets
Vicarious Surgical N/A -68.56% -45.62%
Advanced Biomedical Technologies N/A N/A N/A
淨利潤率 股本回報率 資產回報率
代替性外科 不適用 -68.56% -45.62%
先進生物醫學技術 不適用 不適用 不適用

Analyst Recommendations

分析師建議

This is a breakdown of recent ratings and price targets for Vicarious Surgical and Advanced Biomedical Technologies, as provided by MarketBeat.com.

這是由MarketBeat.com提供的替代外科和先進生物醫學技術最近的評級和目標價細目。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vicarious Surgical 0 1 2 0 2.67
Advanced Biomedical Technologies 0 0 0 0 N/A
銷售評級 保持評級 購買評級 強勁的買入評級 評級分數
代替性外科 0 1 2 0 2.67
先進生物醫學技術 0 0 0 0 不適用
Vicarious Surgical presently has a consensus target price of $9.33, indicating a potential upside of 396.45%. Given Vicarious Surgical's higher possible upside, equities analysts clearly believe Vicarious Surgical is more favorable than Advanced Biomedical Technologies.
目前,該公司的普遍目標價為9.33美元,潛在漲幅為396.45%。考慮到替代外科公司更有可能的上行空間,股票分析師顯然認為替代外科公司比先進生物醫療技術公司更有利。

Volatility and Risk

波動性和風險

Vicarious Surgical has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.

該公司的貝塔係數為0.81,表明其股價的波動性比標準普爾500指數低19%。相比之下,Advanced Biomedical Technologies的貝塔係數為0.61,這表明其股價的波動性比標準普爾500指數低39%。

Valuation & Earnings

估值與收益

This table compares Vicarious Surgical and Advanced Biomedical Technologies' top-line revenue, earnings per share (EPS) and valuation.

此表比較了Surgical和Advanced Biomedical Technologies的營收、每股收益(EPS)和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vicarious Surgical N/A N/A -$35.21 million $0.71 2.65
Advanced Biomedical Technologies $120,000.00 29.54 -$670,000.00 N/A N/A
總收入 價格/銷售額比 淨收入 每股收益 市盈率
代替性外科 不適用 不適用 -3,521萬元 $0.71 2.65
先進生物醫學技術 $120,000.00 29.54 -$670,000.00 不適用 不適用

Advanced Biomedical Technologies has higher revenue and earnings than Vicarious Surgical.

先進生物醫學技術公司的收入和收益比替代外科公司更高。

Insider & Institutional Ownership

內部人與機構所有權

51.8% of Vicarious Surgical shares are held by institutional investors. 52.5% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

代理外科公司51.8%的股份由機構投資者持有。該公司52.5%的股份由公司內部人士持有。強大的機構持股表明,大型基金管理公司、對衝基金和捐贈基金相信,一隻股票有望實現長期增長。

Summary

摘要

Vicarious Surgical beats Advanced Biomedical Technologies on 5 of the 9 factors compared between the two stocks.

在兩隻股票之間進行比較的9個因素中,有5個超過了先進生物醫療技術公司。

About Vicarious Surgical

關於代謝性外科

(Get Rating)

(獲取評級)

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

該公司是美國的一家機器人技術公司。該公司專注於開發和商業化維多利亞系統,這是一種單切口手術機器人,可以虛擬地將外科醫生運送到患者體內進行微創手術。該公司成立於2014年,總部設在馬薩諸塞州的沃爾瑟姆。

About Advanced Biomedical Technologies

關於先進的生物醫學技術

(Get Rating)

(獲取評級)

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

高級生物醫學技術公司是一家處於發展階段的公司,設計、開發、製造和銷售生物材料內固定設備。它提供聚合物骨接合設備,如外科螺絲、捆綁鋼絲、棒和相關醫療設備,用於治療骨科創傷、與運動相關的醫療、軟骨修復和相關治療,以及重建牙科程序。該公司前身為Geostar礦業公司,並於2009年3月更名為Advanced Biomedical Technologies,Inc.。先進生物醫學技術公司成立於2002年,總部設在紐約。

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《替代外科日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收對替代外科及相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論